As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.

As a dedicated rare disease partner, CuraScript SD helps ensure timely access to life-changing treatments.

The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.